features: Alzheimer’s Disease

Therapeutic plasma exchange with albumin replacement to slow cognitive decline in Alzheimer’s disease

The results of the Phase III AMBAR trial were presented at the 2021 EAN meeting. Read on to learn more…

Read More

Plasma pTau181 could differentiate Alzheimer’s disease from other dementias

A recent study published in Nature Medicine has reported advances in the development of a blood test that could help…

Read More
The content of VJNeurology is intended for healthcare professionals